359 related articles for article (PubMed ID: 36831674)
1. A Comprehensive View of the Cancer-Immunity Cycle (CIC) in HPV-Mediated Cervical Cancer and Prospects for Emerging Therapeutic Opportunities.
Avila JP; Carvalho BM; Coimbra EC
Cancers (Basel); 2023 Feb; 15(4):. PubMed ID: 36831674
[TBL] [Abstract][Full Text] [Related]
2. [Preventive vaccines and immunotherapy clinical trials against cervical cancer].
Valdespino-Gómez VM
Cir Cir; 2005; 73(1):57-69. PubMed ID: 15888272
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of human papillomavirus among STD clinic attenders in Jamaica: association of younger age and increased sexual activity.
Figueroa JP; Ward E; Luthi TE; Vermund SH; Brathwaite AR; Burk RD
Sex Transm Dis; 1995; 22(2):114-8. PubMed ID: 7624812
[TBL] [Abstract][Full Text] [Related]
4. The IARC commitment to cancer prevention: the example of papillomavirus and cervical cancer.
Franceschi S
Recent Results Cancer Res; 2005; 166():277-97. PubMed ID: 15648196
[TBL] [Abstract][Full Text] [Related]
5. Immunotherapy for human papillomavirus-associated disease and cervical cancer: review of clinical and translational research.
Lee SJ; Yang A; Wu TC; Hung CF
J Gynecol Oncol; 2016 Sep; 27(5):e51. PubMed ID: 27329199
[TBL] [Abstract][Full Text] [Related]
6. Molecular mechanisms in progression of HPV-associated cervical carcinogenesis.
Gupta SM; Mania-Pramanik J
J Biomed Sci; 2019 Apr; 26(1):28. PubMed ID: 31014351
[TBL] [Abstract][Full Text] [Related]
7. Immune responses against virus and tumor in cervical carcinogenesis: treatment strategies for avoiding the HPV-induced immune escape.
Conesa-Zamora P
Gynecol Oncol; 2013 Nov; 131(2):480-8. PubMed ID: 23994536
[TBL] [Abstract][Full Text] [Related]
8. Estimation of the potential overall impact of human papillomavirus vaccination on cervical cancer cases and deaths.
Van Kriekinge G; Castellsagué X; Cibula D; Demarteau N
Vaccine; 2014 Feb; 32(6):733-9. PubMed ID: 24291200
[TBL] [Abstract][Full Text] [Related]
9. Anal dysplasia screening: an evidence-based analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2007; 7(4):1-43. PubMed ID: 23074504
[TBL] [Abstract][Full Text] [Related]
10. New concepts on risk factors of HPV and novel screening strategies for cervical cancer precursors.
Syrjänen K
Eur J Gynaecol Oncol; 2008; 29(3):205-21. PubMed ID: 18592782
[TBL] [Abstract][Full Text] [Related]
11. Human Papillomavirus Induced Cervical and Oropharyngeal Cancers: From Mechanisms to Potential Immuno-therapeutic Strategies.
Saeed M; Faisal SM; Akhtar F; Ahmad S; Alreshidi MM; Kausar MA; Kazmi S; Saeed A; Adnan M; Ashraf GM
Curr Drug Metab; 2020; 21(3):167-177. PubMed ID: 32316888
[TBL] [Abstract][Full Text] [Related]
12. HPV: Molecular pathways and targets.
Gupta S; Kumar P; Das BC
Curr Probl Cancer; 2018; 42(2):161-174. PubMed ID: 29706467
[TBL] [Abstract][Full Text] [Related]
13. [Prevalence and attribution of high-risk HPV in different histological types of cervical cancer].
Wang WP; An JS; Yao HW; Li N; Zhang YY; Ge L; Song Y; Wang MJ; Yuan GW; Sun YC; Huang MN; Wu LY
Zhonghua Fu Chan Ke Za Zhi; 2019 May; 54(5):293-300. PubMed ID: 31154709
[No Abstract] [Full Text] [Related]
14. Cervical Cancer Immunotherapy: Facts and Hopes.
Ferrall L; Lin KY; Roden RBS; Hung CF; Wu TC
Clin Cancer Res; 2021 Sep; 27(18):4953-4973. PubMed ID: 33888488
[TBL] [Abstract][Full Text] [Related]
15. Vaccination Strategies for the Control and Treatment of HPV Infection and HPV-Associated Cancer.
Farmer E; Cheng MA; Hung CF; Wu TC
Recent Results Cancer Res; 2021; 217():157-195. PubMed ID: 33200366
[TBL] [Abstract][Full Text] [Related]
16. Cervical cancer vaccines: progress and prospects.
Steller MA
J Soc Gynecol Investig; 2002; 9(5):254-64. PubMed ID: 12383909
[TBL] [Abstract][Full Text] [Related]
17. Interventions targeted at women to encourage the uptake of cervical screening.
Staley H; Shiraz A; Shreeve N; Bryant A; Martin-Hirsch PP; Gajjar K
Cochrane Database Syst Rev; 2021 Sep; 9(9):CD002834. PubMed ID: 34694000
[TBL] [Abstract][Full Text] [Related]
18. TIME Is Ticking for Cervical Cancer.
Kumar V; Bauer C; Stewart JH
Biology (Basel); 2023 Jun; 12(7):. PubMed ID: 37508372
[TBL] [Abstract][Full Text] [Related]
19. Human papillomaviruses: The cervical cancer saga in developing countries.
Alhamlan FS; AlAhdal MNA; Al-Zahrani AS; Almatrrouk SA
J Infect Dev Ctries; 2017 Dec; 11(11):819-825. PubMed ID: 31618179
[TBL] [Abstract][Full Text] [Related]
20. Assessment of High-Risk Human Papillomavirus Infection Characteristics in Cervical Squamous Cell Carcinoma and Adenocarcinoma in China.
Zhuang L; Xie X; Wang L; Weng X; Xiu Y; Liu D; Zhong L
Risk Manag Healthc Policy; 2022; 15():2043-2055. PubMed ID: 36348757
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
